Concepedia

Hiroshi Umehara

HU

Statistics

Publications

6

Citations

231

H-Index

6

Active since

2003

Affiliations

Nagoya University(Current)

Kyowa Kirin (Japan)

Hiroshi Umehara is an author at Nagoya University specializing in pharmacology, tyrosine kinase inhibitors, and flt3 inhibitors.

Publications per year

2003–2016

6

Publications

6

KW-2449, a novel multikinase inhibitor, suppresses the growth of leukemia cells with FLT3 mutations or T315I-mutated BCR/ABL translocation

Yukimasa Shiotsu, Hitoshi Kiyoi, Yuichi Ishikawa et al. · Blood · 2009 · 130 citations · Full text

, , +14

A Novel FLT3 Inhibitor FI-700 Selectively Suppresses the Growth of Leukemia Cells with FLT3 Mutations

Hitoshi Kiyoi, Yukimasa Shiotsu, Kazutaka Ozeki et al. · Clinical Cancer Research · 2007 · 29 citations

, , +14

Effect of cisplatin treatment on speckled distribution of a serine/arginine-rich nuclear protein CROP/Luc7A

Hiroshi Umehara, Yoichi Nishii, Masaki Morishima et al. · Biochemical and Biophysical Research Communications · 2003 · 27 citations

, , +4

Epirubicin, Identified Using a Novel Luciferase Reporter Assay for Foxp3 Inhibitors, Inhibits Regulatory T Cell Activity

Hajime Kashima, Fumiyasu Momose, Hiroshi Umehara et al. · PLoS ONE · 2016 · 22 citations · Full text

, , +17

KW-2449, a Novel Multi-Kinase Inhibitor Against FLT3, Abl, FGFR1 and Aurora, Suppresses the Growth of AML Both In Vitro and In Vivo.

Yukimasa Shiotsu, Hitoshi Kiyoi, Kazutaka Ozeki et al. · Blood · 2007 · 12 citations

, , +11

1–5 of 6